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1. Introduction 
Since the 1st successful kidney transplant in 1954 done between two identical twins [Merrill 
etal 1958] organ transplantation has become a life-saving procedure for many disease 
conditions hitherto considered incurable. Clinical organ transplantation has been recognized 
as one of the most gripping medical advances of the century as it provides a way of giving 
the gift of life to patients with terminal failure of vital organs, which requires the 
participation of other fellow human beings and of society by donating organs from deceased 
or living individuals [Ehtuish etal 2006 & Hariharan etal 2000]. The gap between the 
demand for organ transplantation and the supply of donor organs is growing [The 
economist 2008].The waiting list of the United Network for Organ Sharing has grown from 
21,975 names in 2000 to 32,722 in 2008 Fig. (1).  
 
 
Fig. 1. The gap between the demand for organ transplantation and the supply of donor 
organs (UNOS) publications 
The scarcity of organs has dire consequences. And an average of 19 people dies each day 
waiting for a transplant that never comes [United Network for Organ Sharing (UNOS) 
1999]. The World Health Organization WHO global observatory showed that in 2009 about 
100,900 people receive a lifesaving organ transplant, representing only less than 10% of the 
global needs Fig. (2). the entire issue has raised serious ethical concerns and the debate over 
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Fig. 2. Number of Transplants done worldwide WHO publication 
them rages unabated. As further advances are made in such areas as cloning [Savules etal 
1999], the ethical debate should grow more intense. The increasing incidence of vital organ 
failure and the inadequate supply of organs, especially from cadavers, have created a wide 
gap between organ supply and organ demand, which has resulted in very long waiting 
times to receive an organ as well as an increasing number of deaths while waiting. These 
events have raised many ethical, moral and societal issues regarding supply, the methods of 
organ allocation, and the use of living donors including minors. It has also led to the 
practice of organ sale by entrepreneurs for financial gains in some parts of the world 
through exploitation of the poor, for the benefit of the wealthy the ethical questions are 
complicated by an outgoing debate over the definitions of certain key terms such as life, 
death, human, and body. One example is the definition of brain death [Delmonico etal 1973]. 
People have been confused over the issue because of the highly public cases of people 
recovering from comas even after many years. The distinction between the idea of brain 
death and coma becomes a matter that must be clearly defined. A family that is asked to 
donate body organs from dead relative on the basis of brain death must be confident that 
there is no hope of recovering. Other ethical issues of organ donation are considered 
bioethical an important one is the idea of cloning. The technology that would allow the 
cloning of genetically matched clones for the purpose of body harvesting another issue is 
known as xenotransplantation which involves the harvesting of certain compatible animal 
organs for use in humans. A whole new plethora of ethical issues surround this idea due to 
fear from animals and the diseases might transmitted form them, or to protect them, even 
animal rights groups have joined in these debates. There is no question that body donation 
and organ donation will remain a hot topic for many years to come. Organ transplantation 
in general, and kidney transplants in particular, are fraught with ethical issues and 
dilemmas worldwide, about which there is ongoing debate, especially because of the 
shortage of organs The ethical questions associated with transplantation are many [Abouna 
2008]. Is the human body a commodity? How should decisions be made about who should 
receive scarce organs? Who should pay for transplants? Should someone who has received 
one organ transplant be given a second transplant?  Or should people who have not had a 
transplant be given priority over those who have already had one? Should one person 
receive several organs or should several people each receive one? Should one person have a 
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second transplant when the first one fail or should a different person be given a first chance 
at new organ? Should people who have young children be given an organ transplant over a 
single person? Should young people be given an organ transplant over an elderly person? 
Should age and whether or not a person has children even matter? Should organs be given 
to people who have abused their bodies (smoking and drinking etc, ) or only to people 
whose organs are damaged by disease? Should hands or other appendages, which are not 
essential to life, be transplanted? Who can “donate” the organs of people who cannot give 
informed consent to the process? Should money now spent on transplantation be put to 
other uses? Is it possible to prevent the coercion of some donors? Should suicidal 
individuals be given an organ transplant? What if they attempted suicide in the past but are 
not currently contemplating suicide? Should people who can’t afford expensive anti-
rejection drugs be passed over for a transplant? Should people who don’t have Insurance 
and can’t pay for a transplant be allowed to go on the National waiting list? Should 
condemned prisoners receive organ transplants? What if they are serving a life sentence 
without parole? Should country lawmakers be involved in transplantation?  When should 
courts be involved in these questions? 
The questions go on and on; the answers are never simple. Knowing that there are more 
people who need organs than there are organs available, how would you answer these 
questions? Are your answers based on a belief of equal access or maximum benefit 
distribution? 
2. What is organ transplantation? 
An organ transplant is a surgical operation involves removing of an organ from one 
person (donor) and transferring it to another (recipient), keeping the native organs like 
Kidneys or removing them like Livers and Hearts. The need to obtain informed consent 
from both persons (and their surrogate decision-makers) is compulsory. This is in keeping 
with the ethical principle of respect for persons and is expressed in many ethical 
guidelines today. 
3. Important milestones in the history of organ transplantation 
• 1950 – 1954 The first successful kidney transplant. A kidney is taken from one identical 
brother and transplanted in another, where it worked for 8 years. 
• 1960 - 1962 The first successful cadaveric transplant used deceased donor kidney. The 
kidney worked for almost 2 years. 
• 1966 First successful liver transplant. The liver worked for over one year. 
• 1967 First successful heart transplant. The heart worked for 2 1/2 weeks. 
• 1980 – 1981 First successful heart-lung transplant. The organs worked for 5 years. 
• 1982 First artificial heart transplant. 
• 1983 Cyclosporine, an immunosuppressant drug, was approved by the FDA. 
• 1986 A baboon heart was transplanted into Baby Faye and worked for 20days. 
• 1989 The first successful living-related liver transplant. 
• 1990 – 1996 The first “split liver” transplant was performed where one cadaveric liver 
was split into several pieces to transplant into more than one person. 
• 2000 First culture of human embryonic stem cells. 
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4. Types of organ donors 
The sources of organs for transplantation, i.e., living donor (related and nonrelated), 
cadaveric donor, and brain-dead patients. In countries where transplantation is well 
established, organs are sourced from living and cadaveric donors using different strategies, 
i.e., an opt-in (explicit consent), opt-out (presumed consent), and donation after brain death, 
donation after controlled cardiac death, and extended criteria for deceased donors. 
 
 
Gift of Life 
4.1 Living organ donation 
Four categories of donation by living persons can be distinguished: Living Related Organ 
Donation “blood or emotional”: directed donation to a loved one; Altruistic Organ 
Donation: non-directed donation, in which the donor gives an organ to the general pool to 
be transplanted into the recipient at the top of the waiting list; Living Non-Related Organ 
Donation: directed donation to a stranger, whereby donors choose to give to a specific 
person with whom they have no prior emotional connection; and Cross donation where a 
living donor wants to donate to his blood or emotional relative an organ but blood groups 
does not match, there is a complete mismatch or cross matching is positive. Two families or 
more can cross donate if matches exist. Each type of donation prompts distinct ethical 
concerns. Living Related Organ Donation is presumed to be the most ethical form of organ 
donation [Spittal A 1997]. One can argue that the psychological and non-specific benefits to 
the donor are real, particularly when a close relative is returned to normal health. There can, 
however, be no doubt that the physical consequences of living donation are entirely 
detrimental to the donor. Motives behind the 1st degree living renal donation are 
understandable and one may assume that the living donation between relatives carries the 
same altruistic motives. In related organ donation, the donor saves the life and attains the 
wellbeing of its immediate relative by accepting a physical injury and debilitation to itself. 
While many related donors fall neatly into this altruistic categorization, unfortunately, there 
are many examples where the related donors have attained physical, emotional or financial 
toll from the recipient.  With directed donation to loved ones or friends, worries arise about 
the intense pressure that can be put on people to donate, leading those who are reluctant to 
do so to feel coerced. In these cases, transplantation programs are typically willing to 
identify a plausible medical excuse, so that the person can bow out gracefully. Equally 
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important, however, are situations in which people feel compelled to donate regardless of 
the consequences to themselves. In cases like these, simply obtaining the informed consent 
of the relative is insufficient; physicians are obligated to prevent people from making 
potentially life-threatening sacrifices unless the chance of success is proportionately large. 
Non directed donation raises different ethical concerns. The radical altruism that motivates 
a person to make a potentially life threatening sacrifice for a stranger calls for careful 
scrutiny [Garwood etal 2007].  
Transplantation teams have an obligation to assess potential donors in all these dimensions 
and prohibit donations that arouse serious concern. Directed donation to stranger raises 
similar ethical questions with a few additional wrinkles. This type of donation usually 
occurs when a patient advertises for an organ publicly, on television or billboards or over 
the Internet. Such advertising is not illegal, but it has been strongly discouraged by the 
transplantation community. Two central objections are that the practice is unfair and that it 
threatens the view that an organ is a “gift of life,” not a commodity to be bought and sold. 
Some argue that just as we have a right to donate to the charities of our choice, so should we 
be able to choose to whom to give our organs. In practice, however, this means that those 
who have the most compelling stories and the means to advertise their plight tend to be the 
ones who get the organs — rather than those most in need. This strikes some ethicists as 
unfair. Unlike monetary gifts, they argue, organ transplantation requires the involvement of 
social structures and institutions, such as transplantation teams and hospitals. Hence, the 
argument goes, these donations are legitimately subject to societal requirements of fairness, 
and transplantation centers should refuse to permit the allocation of organs on the basis of 
anything but morally relevant criteria [Hull etal 1997]. 
The most ethically problematic cases are those in which the recipient is chosen on the basis 
of race, religion, or ethnic group [Epstein 2007]. A person with organ damage or organ 
failure may look for a living donor to donate an organ, allowing the patient to bypass the 
national waiting pool to receive a cadaveric organ. 
4.1.1 Directed versus anonymous donation 
Currently there is some debate whether altruistic donation should be anonymous or the 
donor should choose the recipient that he wishes to donate the organ to [Epstein etal 2009]. 
Donation could be criticized ethically that it unfairly favors some potential recipients by 
allowing them to jump to the top of 
the waiting list; however, many transplant surgeons and  ethicists believe that this is a very 
special kind of advantage when a good Samaritan donates one of his organs to a friend or 
colleague who is on the waiting list. For this not only helps the recipient, but actually also 
helps those who are on  the waiting list who will move up the ladder and will have a better 
chance of having a cadaveric organ. 
4.1.2 Benefits to living donation [Abouna 1998] 
• The operation can be pre-arranged so, the hot and cold ischemia will be minimized 
which will have a good impact on the transplantation outcome. 
• There are often better matches between donors and recipients with living donation, 
because many donors are genetically related to the recipient. 
• Psychological benefits for both the donors and recipients. 
Not everyone encourages the practice of living donation for all people. 
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4.1.3 Drawbacks of  living donation [Landolt etal 2001] 
• Health consequences: Pain, discomfort, infection, bleeding and potential future health 
complications. 
• Psychological consequences: Family pressure, guilt or resentment. 
• Pressure: Family members may feel pressured to donate when they have a sick family 
member or loved one. 
• No donor advocate: While the patients have advocates, like the transplant surgeon or 
medical team (who are there to advise the patient and work in favor of his or her best 
interests) donors do not have such an advocate and can be faced with an overwhelming 
and complicated process with no one to turn to for guidance or advice. 
A few medical and ethical professionals argue that living donation is inappropriate under 
any circumstances and  should  not only be discouraged  but abandoned all together 
because of the risk and dangers associated with donating organs. 
WHO publications 
Other critics seek to discourage living donation because they think extending life through 
costly and physically taxing medical procedures is not the purpose of health systems. 
Although there are some who object to the practice of living donation, this potential source 
of organs is currently a major focus as a way to reduce the shortage of organs. Increasing the 
number of living donors could occur through a variety of strategies from education and 
civic duty promotion to the sale and purchase of organs Fig. (3). 
 
 
 
 
Fig. 3. International Registry of Organ Donation 
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4.1.4 Justification of transplantation from living donors 
Living related donation, emotional related or altruistic are very justifiable on humanistic 
grounds and they are ethically and medically acceptable, providing that donor evaluation 
both medical and psychological is carried out in accordance with accepted protocols and 
that a fully  informed consent is given by the donor. Also, the rate of donor complications 
after kidney donation is extremely small. The reported mortality rate after kidney donation 
is 1 in 10,000 [Delmonico etal2007]. 
On the side of the donor, there are many psychological and spiritual benefits, and most 
donors express an increased sense of pride and satisfaction and the joy of giving a gift of life 
to a relative, a friend or to another fellow human being. Another justification is that the 
success rate of living donor kidney transplantation is considerably higher than that of 
cadavers [Hunsicker 1999]. The expected patient survival rate and graft function at 5 years 
in 2007 is 99 and 96%, respectively, with living donors and 96 and 91% with cadaver donors, 
which is much better than 1998 statistics and that is most probably due to the recent 
introduction of more effective immunosuppression medications Fig. (4a&b). 
In living donor transplantation it must be shown that the benefits to both donor and 
recipient outweigh the risks associated with donation and transplantation.  
 
 
 
 
Fig. 4a. Patient & Graft survival (UNOS Published Reports) 
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Fig. 4b. Patient & Graft survival (WHO Published Reports) 
4.1.5 The decision to donate organs within the family 
Many decisions to be living donors will be made within a family context - whether blood 
relations or less commonly, spouses, or in-laws - and involve the needs of specific members 
of that family. Very often, in living donation, there will be a host of pressures and family 
complexities to take into account. These may affect the extent to which a decision to donate 
or not to donate is genuinely free. Understanding some of these complexities and family 
dynamics can assist greatly in reaching a decision that is genuinely voluntary. It is 
important to distinguish between different kinds of pressure that a person faced with the 
decision about living donation may feel Avoidable pressures or Unavoidable pressures 
[Spital A 1996]. The decision to be a living donor should be based on adequate information 
and understanding, an informed decision is one based on information relevant to the 
making of that decision. Of course, in assisting a potential donor to make his or her decision 
about donation, doctors have an ethical and legal duty to warn about material risks in a 
treatment [Danovitch 2007]. Material risks are those that most people would want to know 
and also those that would be significant for a particular individual. It follows that a donor, 
before deciding about donation, should ask the appropriate medical practitioner to disclose 
the risks of the intended procedure and of its short and long term effects. 
4.1.6 Psychological issues in live donation 
This includes information and understanding about possible emotional and psychological 
consequences of making a decision one way or the other, for the potential recipient, the 
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potential donor, the relationship between these two people, and for other family members. 
These questions can only be answered within the context of understanding a particular 
family and/or the particular individuals involved whatever the outcome, certain issues may 
take some time to resolve. 
Tissue typing and other medical checks may identify only one suitable donor in a family, 
which can lead to great pressure being put on that person. There may be more than one 
suitable donor and in these cases there can be complex pressures again as a choice is made 
between these people. As examples of such pressures, focus may fall on one of the suitable 
people for various reasons, perhaps without sufficient thought. In other cases there may be 
one person who is extremely eager to donate and so perhaps too willing to overlook 
possible difficulties that may be encountered. Often, such very willing people may need 
even more careful counseling to ensure that their decision is sound. 
Living donation offers the recipient immediate hope. Because the results are generally 
favorable, the mood of the recipient, family and donor are usually optimistic. Against this 
background, other issues need to be considered [Jarvis 1995]: 
Chances of survival of recipient:  
It is argued by some that it is preferable to donate to recipients who are not critically ill, 
because choosing recipients with higher chances of survival better balances the risk to the 
donor. In addition, when such recipients are chosen, there is less need to make a decision 
under pressure and the additional time allows thorough medical and psychological 
evaluation of the proposed donor. 
Changes in donor/recipient relationship:  
The exceptional nature of what has happened and what both the donor and recipient have 
shared may be mutually enhancing. After a donation, there is often increased contact 
between a donor and the recipient where they are known to each other. Our experience 
suggests that reaction to being identified as a donor is very positive [Mathieson 1999]. 
Feeling if the transplant fails:  
If the donation does fail, the donor may have feelings of guilt or inadequacy or feelings of 
anger, sadness, or that the donated organs or tissues have been wasted, and that the 
discomforts he or she has suffered have been made for nothing.  
Feelings of ‘ownership’ towards the recipient:  
Living donors can feel closer to recipients and have expressed attitudes of ownership about 
the state of health and activities of the recipient. They may feel that they have a right to 
ensure that the recipient is taking good care of his or her health and therefore of the donated 
organ or tissue. Conversely, the recipient may identify with the donor and feel that part of 
the donor is living in them. Ultimately such feelings may not be in the best interest of either 
party. 
Recipient feelings of guilt if the donation has harmful effects on the donor:  
A recipient may feel guilty and responsible if the donor suffers from his or her donation. 
Consequences of not donating:  
A decision not to donate can have a major impact on relationships within a family. The 
recipient’s illness is often life-threatening and death may occur before or after 
transplantation. It is therefore important that the family, including prospective donors, do 
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not have unrealistic expectations for the recipient nor underestimate the difficulties for the 
donor. A decision not to donate might be entirely appropriate for the individual, but still 
have profound effects on family relationships if the proposed recipient dies. It is very 
important to consider whether such factors amount to undue pressure on a potential donor 
4.2 Deceased organ donation  
Organs for transplantation which obtained from living donors unfortunately, have so far 
been unable to keep up with demand. As a result, there are a large and steadily increasing 
number of potential recipients awaiting transplantation, some of whom will die before an 
organ can be found. This scarcity of organs for transplantation can only be met from the 
cadavers Fig. (5). Cadaveric source is beneficial in another way that it provides multi-organ 
donation. To utilize cadaveric organs effectively, it needs legal formalities and most of the 
countries have passed cadaveric law [Alashek, Ehtuish etal 2009].  
 
 
 
 
Fig. 5. International Registry of Organ Donation  WHO Publications 
4.2.1 Strategies to promote cadaveric organ donations and self sufficiency 
a. Education  
Educational efforts focus on increasing the number of people who consent to be an organ 
donor before they die. And educating families when they are considering giving consent for 
their deceased loved one’s organs. Social responsibility and the idea of “the gift of life” 
should be  popularized 
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b. Mandated choice 
Under this strategy, every individual would have to indicate his wishes regarding organ 
transplantation, perhaps on driver’s licenses. When a person dies, the hospital must comply 
with their written wishes regardless of what their family may want. The positive aspect of 
this strategy is that it strongly enforces the concept of individual autonomy of the organ 
donor. A mandated choice policy would require an enormous level of trust in the medical 
system. People must be able to trust their health care providers to care for them no matter 
what their organ donation wishes 
c. Presumed consent 
This method of procuring organs is in fact the policy of many European nations. In countries 
with presumed consent, their citizens’ organs are taken after they die, unless a person 
specifically requests to not donate while still living. Advocates of a presumed consent 
approach might say that it is every person’s civic duty to donate their organs once they no 
longer need them (i.e. after death) to those who do. People against presumed consent would 
argue that to implement this policy, the general public would have to be educated and well-
informed about organ donation, which would be difficult to adequately achieve. Doubters 
of the presumed consent approach might also argue that requiring people to opt out of 
donating their organs requires them to take action and this might unfairly burden some 
people. The countries having presumed consent principles like Spain and Canada shows 
higher donation rate 40-50 per million population [Miranda etal 1998 & Rithalia etal 2009]. 
d. Incentives 
Incentives take many forms [Beier etal 2008]. Some of the most frequently debated incentive 
strategies are: 
1. Give assistance to families of a donor with funeral costs 
2. Donate to a charity in the deceased person’s name if organs are donated 
3. Offer recognition and gratitude incentives like a plaque or memorial 
4. Provide financial or payment incentives 
One of the most highly debated incentives would give donating families assistance with 
burial or funeral costs for their loved one this could be an attractive incentive for many 
families.  
Proponents say that since the person will be dead and unable to receive the recognition, that 
this would not be a coercive action. Some ethicists believe that many of the incentives above, 
while not attached directly to cash money, are still coercive and unfair. They believe that 
some people will be swayed to donate, in spite of their better judgment, if an incentive is 
attractive enough. They further argue that a gesture may seem small and a mere token to 
one person, but others might interpret it quite differently. A final anti-incentives argument 
offered by some ethicists discourages the practice of incentivizing organ donation [Jasper 
etal 1999]. They believe that society should instead re-culture its thinking to embrace a 
communitarian spirit of giving and altruism where people actively want to donate their 
organs  
4.2.2 Maximizing donation form deceased donors 
In order to maximize the donation from deceased donors it is important to consider the 
following:  
• Legal and organizational framework 
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• Coordinating authority over health system 
• Citizen's understanding: donation in school curriculum 
• Ongoing reality and momentum in media 
• Adaptation of relevant models (Spain) in emerging countries  
4.3 Minors and children as donors 
It is another issue that needs considerate discussion. Living donors provide the best 
outcome for children undergoing renal transplantation. Most of these donors are parents. 
When parents are unable to donate, siblings are often considered. But what if the siblings 
are also children? Should they be permitted to donate? They are below 18 years of age and 
not able to consent and they might be pushed or convinced to donate. And what about those 
who are mentally subnormal and their families wants to use them as donors? 
Sometimes there are reports that children have been kidnapped, only to re- appear later 
lacking one kidney, or that they simply disappear and are subsequently killed to have all 
their transplantable organs removed for profit. However, the issue is covered in a broader 
sense by more general provisions. There are endless rumors surrounding this area. Members 
of various organizations who travel in the suspected countries say that the trafficking in 
children who are sold for transplantation is well known, but it is too difficult and very 
dangerous to catch the people involved [Spital A 1997],  
4.4 Executed prisoners as donors 
Several authors and ethicists have recently commented on the current practice in some 
countries of the use of organs from executed prisoners. While all societies strongly condemn 
the arbitrary use of taking organs from executed prisoners, which is a common practice in 
some countries, where organs are taken and given to various institutions for transplantation 
or even sold to other countries. It is suggested that it will be ethically permissible to allow a 
prisoner on death row to donate an organ to a relative or a friend. [Miller 1999]. 
One argument in favor of taking organs from prisoners, who are put to death, is that it is the 
execution that is ethically unsound and not the organ removal. Indeed, in light of  the severe 
organ shortage, some ethicists could  make  the argument that to not use the organs for 
transplantation is wasteful. Some ethicist, put forth the argument that obtaining organs from 
condemned prisoners is allowable if the prisoner or their next of kin consents to donation, as 
long as organ donation is not the means by which the prisoner is killed because that violates 
the principle that a cadaveric donor be dead prior to donation. Some could argue that organ 
retrieval from executed prisoners is morally justifiable only if a “presumed consent” 
donation practice was in place. Many, if not most, bioethicists consider taking organs from 
condemned prisoners a morally objectionable practice. And immoral [Cameron etal 1999].  
4.5 Alternative organ sources 
Some potential non-traditional sources of organs are: 
4.5.1 Animal organs – “xenotransplantation” 
Animals are a potential source of donated organs. Experiments with baboon hearts and pig 
liver transplants have received extensive media attention in the past. One cautionary 
argument in opposition to the use of animal organs concerns the possibility of transferring 
animal bacteria and viruses to humans. Some argue that xenotransplantation is the only 
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potential way of addressing this shortage. As immunological barriers to xenotransplantation 
are better understood, those hurdles are being addressed through genetic engineering of 
donor animals and the development of new drugs therapies [Starzl etal 1964 & Grant etal 
2001]. The focus of ethical attention has changed from the moral correctness of using 
animals for research/therapy to an increasingly appreciated danger of the establishment 
and spread of xenozoonses in recipients, their contacts and the general public. There are a 
number of reasons for not using subhuman primates for xenotransplantation, including 
their closeness to humans, the likelihood of passing on infections, their availability (gorillas, 
chimpanzees), their slow breeding and the expense of breeding them under specified 
pathogen free conditions. The pig, although domesticated and familiar, is too distant to 
evoke the same feeling as we have for primates, has the correct size organs, is probably less 
likely to pass infections, breeds rapidly and is not endangered; moreover, millions of them 
are eaten every year. Although drawing ethical conclusions is difficult at the stage of 
knowledge and debate, it seems acceptable to manipulate pigs genetically and to proceed to 
using their organs for xenotransplantation trials when infection control measures and the 
scientific base justify it [Bukler etal 1999 & Sim etal 1999]. The use of pigs in Muslim 
countries would be more controversial and disruptive although it is acceptable by Islamic 
religion in case of a real need and when there is no alternative [Rahman 1998]. In this case 
the question of informed consent is likely to be ambiguous and awkward. It might end up 
more of a binding legal contract than consent, as we understand it now. Xenotransplantation 
is also unlikely to cost less than or significantly alleviate the shortage of cadaveric organs in 
the short term. The international dimension of the risk of infection is becoming obvious, but 
there has so far been no effort to convene an international forum to agree on universally 
acceptable guidelines However, before xenotransplantation can be fully implemented, both 
the scientific/medical communities and the general public must seriously consider and 
attempt to resolve many complex ethical, social and economic issues that it presents [Platt 
1999]. 
4.5.2 Artificial organs  
Artificial organs are yet another potential option. 
The ethical issues involved in artificial organs often revert to questions about the cost and 
effectiveness of artificial organs. People who receive artificial organ transplants might 
require further transplanting if there is a problem with the device. 
4.5.3 Organs from fetuses 
The ethics of using tissues and organs from fetuses have been a matter of enormous 
discussion. Aborted fetuses are a proposed source of organs. Debates address whether it is 
morally appropriate to use organs from a fetus aborted late in a pregnancy for 
transplantation that could save the life of another infant. Many people believe that this 
practice would encourage late-term abortions, which some individuals and groups find 
morally objectionable. Another objection comes from people who fear that encouraging the 
use of aborted fetal organs would encourage “organ farming,” or the practice of conceiving 
a child with the intention of aborting it for its organs[Golmakani etal 2005]., but the use of 
spontaneously aborted fetus or anencephalic newborn could be encouraged. Although there 
is ethical debate concerning the possible use of organs of anencephalic babies for transplant. 
Some have argued that because of the absence of neocortex these are ‘nonpersons ‘and are 
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‘brain-dead’ and thus, such infants should be available for organ donation if this is the wish 
of the parents. However, as brain stem function is present in these infants, the ‘whole of the 
brain’ or ‘brain stem’ requirement for certification of brain death precludes removal of 
organs until cardiorespiratory death occurs. 
4.5.4 Stem cells –“The future” 
Stem cells are cells that can specialize into many different cells found in the human body. 
Researchers have great hopes that stem cells can one day be used to grow entire organs, or 
at least groups of specialized cells [Bartholomew etal 2001 & Eradini 2002]. Some of the very 
recent developments in transplantation over the past decade have been the use of stem cells 
from bone marrow, cord blood, and from fetal and adult tissue, including somatic cells and 
neural cells. These cells have the great potential for differentiation and proliferation into 
other types of body cells including neuronal, hepatic, hemopoietic and muscular and thus 
help many patients with organ failure after their transplantation into the patients. These 
stem cells have also been shown to induce immunological tolerance and chimerism when 
they are transplanted into recipients of vital organ grafts and their rejection of a 
transplanted organ such as bone marrow, kidney, heart, liver, is prevented [Fandrich 2002]. 
A new hope is emerging now with the possibility of preserving the architecture of an organ 
i.e. preserving capsule, vascular structures and draining system and removing the destroyed 
or fibrosed cells and replace them with new cell mass produced by stem cells like removing 
all non-functioning Hepatocytes and replacing them with a new Hepatocyte cell mass, The 
ethical objections concerning stem cells have focused primarily on their source. While stem 
cells can be found in the adult human body, the seemingly most potent stem cells come from 
the first few cells of a human embryo. When the stem cells are removed, the embryo is 
destroyed. Some people find this practice morally objectionable and would like to put a stop 
to research and medical procedures that destroy human embryos in the process. 
5. Life & death 
With the development of mechanical ventilators, new drugs, and other forms of treatment, it 
became possible to artificially maintain circulatory and respiratory functions, even after 
the brain had stopped functioning. In the past four decades many countries amended their 
death statutes to include a definition of death by the complete and irreversible cessation of 
all brain functions. Since that time almost all cadaveric organs have been recovered from 
patients who have been declared "brain dead." Veatch has never been comfortable with the 
term "brain death," preferring instead "brain-oriented definition of death." Since the 1970s he 
has argued that the entire brain does not have to be dead for the individual as a whole to be 
dead. Instead, he advocates a "‘higher-brain-oriented definition’ of death—in other words, 
one is dead when there is irreversible loss of all ‘higher’ brain functions" he further proposes 
creating a new definition of death law that incorporates the notion that one need only 
have an irreversible loss of consciousness as opposed to an irreversible loss of all brain 
functions [Veatch 2008]. Veatch’s proposal is clearly controversial. It suggests a violation of 
an ethical boundary most clinicians are currently unwilling to cross. Perhaps he is correct 
that such a change is inevitable and that the "definition of death at the conceptual level is a 
religious/philosophical/social policy choice rather than a question of medical science" 
.There was clear leadership from individuals such as pioneering transplant surgeon, Dr. 
David Hume; Dr. Hume wrote “there is only one definition of death, irreversible brain 
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damage. Cessation of heart beat does not constitute death unless it has caused irreversible 
brain damage there must be no spontaneous respirations” [Delmonico 2010]. These 
observations were later corroborated by Dr. William Sweet published in the New England 
of Medicine when he wrote “it is clear that a person is not dead unless his brain is dead 
[Sweet 1978]. The time-honored criteria of stoppage of heart beat in circulation are long 
enough for the brain to die”. Dr. Sam Shemie has clarified the paradigm for donation and 
death by emphasizing on the “required absence of circulation” and by underscoring the 
vital functions of the brain as an essential criterion of life [Shemie 2007]. “Where the 
extracorporeal machines of transplantation can support or replace the function of organs 
such as the heart, lung, liver or kidney, the brain is the only organ that cannot be supported 
by medical technology”. On the other hand Byrne and others have rejected brain death as 
constituting death of the person contending the “cessation of the entire brain function, 
whether irreversible or not, is not necessarily linked to total destruction of the brain or the 
death of the person”. Byrne, apparently, bases his opinion regarding death as 
philosophically constituting a separation of the soul from the body [Byrne 1979]. However, 
applying that personal philosophy to the diagnosis of death defies a legal and medical 
standard, and an ethical and practical sensibility. No one knows when the soul may separate 
from the body at the time of death. However, the legal and medical definition of death is 
clear in terms of neurological and circulatory function. It becomes unethical to impose futile 
clinical treatments to a comatose individual, if the function of the entire brain is irreversibly 
lost. What would opponents of the brain death determination do with a patient on a 
ventilator with such a clinical condition have them maintained indefinitely in such a state? 
To propose the brain death criteria as constituting death was the central issue that 
confronted the Harvard Committee in 1967 [Ad Hoc 1968]. No one knows when the soul 
separates from the body, but a precise time of death must be specified for obvious legal, 
medical and social reasons, so that futile treatment can be concluded (without further 
obligation or responsibility to provide resuscitative or supportive technologies) and proper 
disposition of the body with burial and estate and property transfer, etc can be exercised. 
For many years, Truog has also objected to the determination of death by neurologic 
evaluation and by circulatory function. He wrote in the New England Journal of Medicine 
that “arguments about why these patients should be considered dead have never been fully 
convincing [Truog 1997]. The definition of brain death requires a complete absence of all 
functions of the entire brain yet many of these patients retaining essential neurologic 
function, such as regulated secretion of hypothalamic hormones”. The rebuttal to this 
assertion has been given by Shemie [Shemie etal 2006] who claimed that “the release of 
antidiuretic hormone (ADH) from the hypothalamus is not considered to be essential 
neurologic function. Brain death is determined by an absence of consciousness, receptivity 
and responsiveness, spontaneous movement, spontaneous breathing and absence of 
brainstem reflexes”. Brain death does not require every brain cell to be nonviable but the 
criteria require an irreversible loss of neurologic function of a patient interminably 
supported by a mechanical respirator. For Truog and others however, these patients are not 
considered dead because they indeed can be supported indefinitely beyond the acute phase 
of their illness. It is well known however that despite the irreversible loss of brain function 
the remainder of the body can be maintained by mechanical support; for example, even by 
patients who become brain-dead during pregnancy yet successfully have their fetuses 
brought to term. The clinical condition still constitutes the death of the mother and a viable 
fetus buys continued mechanical support until birth. Again in the New England Journal of 
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Medicine. Truog and Veatch [Veatch 2008 &Truog etal 2008 & Life 9 November 1962] have 
asserted the donation after cardiac death (DCD) is not acceptable; that is, the recovery of 
organs after the determination of death by circulatory and respiratory criteria. Troug 
suggests that recovery of the heart following DCD is “paradoxical” because the hearts of 
patients who have been declared dead on the basis of the irreversible loss of cardiac function 
have in fact been transplanted and successfully functioned in the chest of another”. Veatch is 
similarly not convinced that the donor is dead and stated that “if someone is pronounced 
dead on the basis of irreversible loss of heart function, after all. It would not be possible for 
heart function to be restored in another body. Both Veatch and Truog misinterpret the 
uniform declaration of death act UDDA which precisely stated that it applies to an 
individual who had sustained irreversible cessation of circulatory and respiratory functions. 
It is not a matter of the cessation of heartbeat or cardiac function per se but an irreversible 
cessation of circulation in the donor. The consequence of the absence of circulation is upon 
the function of the brain results in an irreversible loss or neurologic function – the UDDA 
definition of death [Ad Hoc committee 1968 & President Commission 1981 & Delmonico etal 
1999].  
Bernat has written that circulation – not heartbeat – is the critical function that must be 
lost using circulatory-respiratory tests to determine death [Bernat 2008]. For example, we 
do not declare patients dead who are on heart lung machines during cardiac surgery, on  
ECMO awaiting heart transplantation (even if they never receive a heart), or carrying 
artificial hearts because, despite absence of heartbeat, their circulation remains 
continuously maintained. That is why the death standard requires absence of circulation. 
“Whether the asystolic heart is subsequently left alone, removed and not restarted or 
removed and restarted in another patient is irrelevant to the circulatory status of the just-
declared dead patient [Norton 1992]. Removing and restarting the heart elsewhere simply 
has no impact on the previous death determination because that patient remains 
permanently without circulation in exactly the same way as if the non-beating had been 
left in place”. And as an everyday example after slaughtering the rooster it jumps higher 
and stronger as never than done in its life, this movement doesn’t indicate that he is still 
alive and it continues bleeding strongly indicating that the heart is still functioning, and 
on the opposite side the heart beating may stop spontaneously, known as cardiac arrest 
and attempts of rescue continue, in many cases the restitution succeed. The heart start 
beating again and life gets back to its normal state, moreover doctors can stop the heart 
for hours during the operation of the open heart, however the blood circulation does not 
stop, not even for seconds, therefore the heart beating does not mean life and the stoppage 
of heart beating does not necessarily  mean death. Irreversible loss of consciousness may 
be due to partial or total brain injury [Shewmon 1998]. For the determination of brain 
death, irreversible coma must be due to injury to the brain so severe as to cause loss of 
brain functions 
Death is when blood stop reaching the brain causing a permanent harm to the brain and 
leading to a permanent loss of all its functions including the brainstem functions and to 
diagnose death it is necessary to prove the cessation of the functions of the brain, and then 
brain commences disintegration and its known that many cells from a dead person remain 
alive after the declaration of his death. Therefore we find that the muscular cells responds to 
electrical stimulations and some cells within the liver continue transforming the glucose to 
glycogen, so cells do not die all at once, however they differ in their timing of death and 
perish after death of the person. We can extend the life of these cells if they are put in saline 
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solution, especially with the flow by means of a pump hence allowing the use of organs and 
cell of the dead person for another patient needing them, the death is a process and not an 
event. 
Brain death can be defined as follows: When the brain is damaged, and its activities 
completely cease, brain death is present, even if it is possible for the patient to be kept 
breathing and his heart is beating with artificial respiration and medications; even if the 
heart and liver are functioning that is not live it is just artificial. The consideration of legality 
of brain death as “true death” was first considered in the early 1960’s; with the 1968 
Harvard report becoming the “standard” definition of brain death. the majority of countries 
and international professional associations have accepted it. 
5.1 Islamic opinion 
The majority of Muslim jurisprudents consider organ transplantation to be permissible on 
the basis of principles that needs of the living outweigh those of the dead. Saving a life is of 
paramount value in Islam as the following verse from the Quran illustrates “And if any one 
sustains life, it would be as if he sustained the life of all mankind” [Ebrahim 1995 & Ebrahim 
1998 & Van Bommel 1999 & Al Faqih 1991]. The Islamic jurisprudence Assembly Council in 
its meeting in Saudi Arabia on Feb 6-11, 1988 ratified resolution number 26.1.41 declared the 
following fatwa the permissibility of proxy consent: “Transplantation of an organ of the 
dead to a living human being whose life or essential function of the body would rely on the 
donated organ is allowed, provided that the dead (before his death) or his heirs permit it. 
Shiite scholars have made similar rulings. The majority of Shiite jurisprudents confirm 
organ transplantation especially when human life is at stake.[Moqaddam 2000 & Ghods etal 
2006 & Zargooshi 2008]. 
Ordinarily, the dead have a right in Islam to the sanctity and wholeness of their body, but as 
we have already noted, the need to save a life overrides this injunction as it has a prima facie 
importance in the mundane affairs of mankind. While saving a life is of paramount 
importance in Islam, the family of the deceased must consent and there are in no way 
obliged to consent to organ donation even if it involves the death of another person who is 
alive but gravely ill. It has been reasoned that the “ownership” of organs, like that of 
property, is relative and subjective because God is the ultimate “owner” of the universe 
having created it. Therefore, it would be permissible to donate them because God had 
placed great value on saving a life. 
5.2 Church opinion 
In the address of pope John Paul II to the Transplantation Congress in Rome in 2000, 
regarding the determination of death, he said …”it is helpful to recall that the death of the 
person is a single event, consisting in the total disintegration of the unitary and integrated 
whole that is the personal self”. And that “it is a well-known fact that for some time certain 
scientific approaches to ascertaining death have shifted the emphasis from the traditional 
cardio respiratory  signs to the so-called neurological criterion. Specifically, this consists in 
establishing, according to clearly determined parameters commonly held by the 
international scientific community, the complete and irreversible cessation of all brain 
activity (in the cerebrum, cerebellum and brain stem). This is then considered the sign that 
the individual organism has lost its integrative capacity” [Abouna 1984 & Pope John Paul II 
2000]. 
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6. Brain death is death 
6.1 Misuse of terminology 
Patients who fulfill the brain function criterion for death are commonly said to be ‘brain 
dead’. This term, unfortunately, suggests that there are two ways of being dead, being ‘brain 
dead’ and being ‘really dead’. The term ‘brain death’ is also used, incorrectly, in other 
contexts to describe much lesser degrees of neurological dysfunction than it strictly implies. 
This misuse of the term is to be found in the medical and related professions as much as in 
the general public. It has lead to confusion surrounding the idea of a brain function criterion 
and its relation to ‘brain death’. It may be that it is too late to reclaim the term for its 
legitimate use. Whenever it is used, it is important that it is sufficiently qualified to ensure 
that its meaning is clear, and professional medical bodies may have a role to play in 
encouraging correct application of the term. 
6.2 Explaining brain function criterion to the family of the deceased donors 
Even apart from confusion over the use of the term ‘brain death’ it can be very difficult for 
families to fully understand the reality of death based on a brain function criterion. To 
casual observation, patients fulfilling the brain function criterion for death appear to be 
sleeping rather than dead. The skin is warm. The chest rises and falls with mechanical                          
ventilation. The heart and the kidneys continue to function. There are even reports that 
pregnancy may be maintained in patients fulfilling the brain function criterion for death. 
This ambiguity is reflected in the way medical and paramedical staff relates to the beating-
heart cadaver in the period before organ donation. Nurses will often talk to such a cadaver 
as they carry out their nursing care as if the body retained the ability to hear. Acceptance of 
death by the brain function criterion in the context of organ donation asks much more of a 
family than does the same diagnosis with a view to cessation of treatment. Community 
education programs might go part way in helping families understand the issues involved. 
Detailed explanations with appropriate written material should be provided. Practitioners 
dealing with families should be trained in the process of explaining the brain function 
criterion and in grief counseling in general. Families should be provided with the 
opportunity to ask relevant questions and to have their questions answered in a genuinely 
sympathetic environment. Sufficient time should be provided to ensure that families really 
understand the brain function criterion before the issue of organ donation is broached. 
Families should then be allowed whatever time and assistance are necessary to make a 
decision concerning organ donation and then to deal with the particular grieving problems 
over the ensuing days and weeks. They should be offered the opportunity to view the body 
after the retrieval process has occurred when it has the appearance of being dead [Shemie 
etal 2006 & Delmonico etal 1999 & Norton 1992]. 
6.3 Deciding to donate or not to donate organs after death 
The main reason why people may consider donating organs is because of the very great 
benefit that this can bring to others. Organ transplantation may be a lifesaving treatment for 
patients with liver or heart disease, and it may be the only hope of treatment there is. For 
kidney patients, having a transplant can mean being able to cease, and this can bring a great 
improvement in health and lifestyle. For instance, it may enable a kidney patient to return to 
the workforce, or to work longer hours, and it can even mean that a woman can now have a 
baby. The transplantation of a cornea can give someone back his or her sight [Ehtuish etal 
2006 & Abouna 1998 & Hunsicker 1999 & Alashek etal 2009 & Cohen etal 1995].  
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Transplantation is generally a very successful procedure. The success rates of 
transplantations vary, but in all cases these have increased considerably since 
transplantation first began (Fig. 4b). It can be difficult in medical science to predict which 
procedures will become more successful and eventually routine. However, kidney 
transplantation is now considered to be accepted medical treatment and this is likely to 
happen in other areas of transplantation. Some people decide not to donate organs because 
they are not confident that donation would be in accordance with their dead relative’s 
wishes. Some people think that transplantation is a very costly procedure from which 
relatively few people benefit. If you believe that your family may gain some comfort from 
donation, this may be a reason to consider it for yourself. On the other hand, if you feel that 
your family may be upset about donation, you may decide against it. This shows the 
importance of discussing donation with your family. You need also to bear in mind that the 
people who donate organs are mostly those who have died suddenly and unexpectedly and 
they are often quite young. For the families of these patients, death may be especially 
traumatic. When deciding about donation for yourself before death, you may begin by 
thinking of how you would feel if you were in the position of needing lifesaving organ or 
tissue transplantation. In making your decision, you also may feel, for instance, that you no 
longer need your body, and would like to feel that you had done something to help others. 
Or you may feel that it is important that your body remains intact for burial or cremation. If 
you belong to a religious faith, you may want to consider how organ donation and 
transplantation is understood from that religious point of view. Indeed you may wish to 
consult a religious advisor on the appropriateness of organ donation in your particular 
circumstances. 
6.4 Making a decision when a relative has died 
Deciding about organ donation on behalf of a loved relative who has just died may be a very 
difficult decision to make. Often the relative’s death will have been the result of a traumatic 
event such as a car accident or a head injury. This makes the death an especially sad one for 
family and friends,  means that people are asked to make a serious decision at a difficult, 
stressful and emotional time. You may feel shocked, bewildered, angry, and numb [Norton 
1992]. But, for practical reasons, if organ donation is to occur, it must take place within a 
certain time period: so there will be only a limited time in which to make this decision. The 
difficult circumstances in which the decision has to be made make it all the more important 
that you are well-informed and that you feel confident that you have considered the matter 
as fully as you wish. Families are greatly assisted in their decision-making at a time of crisis 
if they have previously discussed organ and tissue donation and the wishes of individuals 
are known. There are three scenarios that need to be considered: (1) Your relative dies 
having made known his or her wish to donate organs after death: in this case the family is 
consulted in order to clarify what the person’s wishes were in relation to organ donation 
and to see whether the family has any objections to the deceased’s wishes being acted on. 
Donation will not proceed in the face of objection from families. If you know that your 
relative wished to donate his or her organs and/or tissues, this may provide you with a 
substantial reason for you to consent to the request for donation. Islamic religion respect the 
intestate and wishes of the person before he died and the relatives are obliged to implement 
the intestate that is clear in many verses in Quran.  (2) Your relative dies having made 
known to you his or her wish not to donate organs: in this case, made this known to hospital 
staff and organ donation will not be discussed further. (3) Your relative dies and either had 
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no views about organ donation (as in the case of a young child) or had not made his or her 
views known to you: in this case the hospital authorities will consult the family to find out 
whether anything is known about the deceased person’s wishes and/or to find out whether 
the family will consent to donation on behalf of their deceased relative. One thing that you 
may like to do in this situation is to make a judgment based on your knowledge of that 
person. What was his or her attitude to transplantation: had he or she ever shown any sign 
of being in favor or against it? What were his or her beliefs and feelings about the body and 
about how it should be treated after death? Was he or she the kind of person who would 
want to help others? Would he or she have been likely to have discussed organ donation 
with someone outside the family? It is professional practice not to pressure people in any 
way. The decision that you have to make is not a purely rational or ‘head’ decision but also 
an emotional or ‘heart’ decision. You may need time to come to terms a little more with the 
emotional significance of events, may be to accept that your relative really is dead. You may 
wish for time to imagine how you may feel afterwards, whatever decision you make; and 
how others in your family may feel. You may feel you need time alone, or time with just 
your family [Evans 1993 & Courtney etal 2009]. 
6.5 Some key questions you might consider in case of organ donation 
Do I think that donating organs and/or tissues for transplantation (or other purposes) is a 
worthwhile cause? How would I feel if I needed a transplanted organ? How does organ 
donation fit with my religious, spiritual and moral beliefs? How would I feel if a friend or 
relative needed an organ? What do my other family members think about organ donation? 
Have I made my wishes about organ donation known to my family?  If I decide I want to 
donate organs, how will this affect my family? Am I satisfied that I understand the concept 
of ‘brain death’ as a way of determining death? Do I feel that I could trust the medical staff 
involved if I were ever in a situation to be a potential organ donor? How do I think of my 
body after death? Are there some organs I would like to donate, and not others? Will my 
family try to carry out my wishes? Will counseling be available for my family if they need 
it? Am I satisfied that respect will be shown to my body? Are there other people I would like 
to consult? [Miranda etal 1998 & Jasper etal 1999 & Cameron etal 1999 & Cohen etal 1995] 
7. Entry of patients to transplantation programs 
Decision-making becomes necessary at two stages of the process of organ and tissue 
allocation. The first stage deals with those considerations which should be taken into 
account in deciding on the identity of the individual patients to whom offers of transplants 
are to be made. Decisions of this type, by reason of the technical details involved, will 
remain a responsibility of medical personnel. Entry to, and exclusion from, a transplantation 
program both raise ethical issues. 
Entry to a program is offered following assessment of patients by the program personnel. 
Exclusion criteria include age restrictions, abnormalities in other organ systems, previous 
history of malignant disease and other medical considerations. In making decisions about 
which patients are to be admitted to a program, there is merit in more than one medical 
practitioner being involved.  
The second stage of decision-making relates to whether an individual chooses to become a 
transplant recipient. This is a decision to be made by the patients in the light of advice 
received from their medical attendants and consultation with their families. Acceptance of 
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the offer requires an informed decision on the part of a patient and/or their family. Prior to 
this decision, a patient should receive a full description of what is entailed in being in the 
program, what procedures can be expected and their possible risks and benefits. On the 
other hand, if a patient is excluded from a transplantation program, he or she is entitled to 
know why? [Turcotte etal 1989]. 
In an attempt to ensure that transplanted kidneys have the best outcome possible for 
individual patients, concurrent medical conditions that introduce a potential risk following 
transplantation should be managed before acceptance on to the waiting list, If a pre-existing 
condition is likely to be affected adversely by the ongoing immunosuppression required 
after transplantation (for example, immunosuppression increases the risk of recurrence of 
cancer and of persistence of chronic infection) a patient may be excluded from 
transplantation in his or her own interest. Though some may think it is unfair to deny a 
patient the opportunity to receive a transplanted kidney because of renal disease which 
could recur in the graft, others might consider it unreasonable to inflict repeated 
transplantation when there is a high risk of rejection. In rare circumstances, the kidney 
allocation system may be suspended to provide an organ for transplantation to a critically ill 
patient. To ensure fairness in allocation, the selection criteria and weighting of different 
criteria are subject to repeated review by personnel from all institutions involved in renal 
transplantation. 
7.1 Factors influencing entry to, and ranking in, a transplantation program 
a. The patient sickness. 
b. The patient most likely to benefit based on medical or other criteria. 
c. The length of the patient on the waiting list. 
d. All patients on the waiting list should have an equal chance. 
e. The patient’s importance for the well-being of others, for example previous organ 
donors. 
f. The patients who have previously had one or more transplants. 
g. Capacity of the patient to pay. 
8. Allocation of kidneys 
The allocation of kidneys occurs under circumstances not paralleled in the case of other organs 
because candidates for transplantation are drawn exclusively from patients already within a 
dialysis program. This introduces the difficulty that, whereas selection to receive a kidney is 
determined by clearly defined and promulgated criteria that are uniformly applicable 
nationally, selection to enter dialysis programs is affected by a variety of sets of guidelines. In 
some cases uniform criteria for entry to dialysis are being formulated. However, in other 
instances, individual clinics have their own guidelines, not all of which are readily available. 
This lack of transparency precludes ethical assessment of the procedures employed and this 
should occasion concern: it is an ethical issue in itself. As kidneys can be preserved safely by 
simple cold storage for at least twenty-four hours, the results of a blood T-cell cross match and 
tissue matching can be available before transplantation is undertaken. Because of the length of 
waiting lists, several potential recipients are commonly equally well matched with each 
presenting donor. Allocation of kidneys should be organized on a national basis so that 
recipients with the closest tissue matching with the donor are selected to receive the organs. 
This provides the best chance of success. Currently, kidneys are raised by allocation of 
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transplant resources allocated to potential recipients according to the best available tissue 
match. If there are no suitably matched potential recipients on the national waiting list, the 
length of time on dialysis usually determines the recipient. Factors such as recipient age, 
period on dialysis, pre-sensitization to tissue antigens, presence of diabetes mellitus and the 
previous receipt of a transplant are likely to be taken into account.  
The concept of distributive justice – how to fairly divide resources – arises around  organ  
transplantation. Distributive justice theory states that there is not one “right” way to 
distribute organs, but rather many ways a person could justify giving an organ to one  
Particular individual over someone else. Equal access criteria include [UNOS 2001]: 
• Length of time waiting (i.e. first come, first served) 
• Age (i.e. younger to younger, older to older or youngest to oldest) 
•  Organ type, blood type and organ size 
• Distance from the donor to the patient 
• Level of medical urgency  
Equal access supporters believe that organ transplantation is a valuable medical procedure 
and worth offering to those who need it. They also argue that because the procedure is 
worthy, everyone should be able to access it equally.  
Successful transplants are measured by the number of  life years gained. Life years are the 
number of years that a person will live with a successful organ transplant that they would 
not have lived otherwise. This philosophy allows organ procurement organizations to take 
into account several things when distributing organs that the equal access philosophy does 
not – like giving a second organ transplant to someone who’s already had one or factoring 
in the probability of a successful medical outcome. 
Three primary arguments oppose using the maximum benefit distribution criteria. First, 
predicting medical success is difficult because a successful outcome can vary. Is success the 
number of years a patient lives after a transplant? Or is success the number of years a 
transplanted organ functions? Is success the level of rehabilitation and quality of life the 
patient experiences afterward? These questions pose challenges to those attempting to 
allocate organs using medical success prediction criteria. The second argument against 
maximum benefit distribution is that distributing organs in this way could leave the door 
open for bias, lying, favoritism and other unfair practices more so than other forms of 
distribution due to the subjective nature of these criteria. Third, some ethicists argue against 
using age and maximizing life years as criteria for distributing organs because it devalues 
the remaining life of an older person awaiting a transplant. Regardless of how old someone 
is, if that person does not receive a transplant they will still be losing “the rest of his or her 
life,” which is valuable to everyone. 
9. Organ trafficking  
Organs trading 
The transfer, traveling, hosting, receiving living or deceased persons, or their organs, 
through threat, by force or any other forms of oppression or kidnapping or fraud, or deceit, 
or misuse of power or position, mis-receipt by a third party of money or subsidies submitted 
to oppress the contingent donor and use him as an organ donor. 
Commercialization of organs 
It is the policy or conduct by which the organ is dealt with as if it is a trade goods, including 
their purchase, sale or use for material gain. 
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Travel for organs transplantation 
It is the travel of organs, donors, recipients or professionals of organs transplantation over 
the international borders for purpose of organs transplantation.  
9.1 Methods and means used for organ trafficking and transplant tourism 
The donor, recipient and surgeon may be of the same country. The agreement may be done 
before they get to the surgeon. The donor and recipient may travel to the country of the 
surgeon. The patient may travel to the donor country and vice-versa. The donor may be 
from one country, the patient from another country and the surgeon from third country, and 
all may travel to a fourth country to perform the transplantation  
[Bramstedt 2007] Fig (6a&b). This needs organizers and coordinators, until the matter 
arrived to the existence of organized gangs aiming for benefit and do not care of the donor 
or the patient. They are standing on extortion principle and earning profits on the account of 
poor people and those in need. The matter arrived to even stealing organs, yet to kidnap 
children and women and even men in order to get their organs for selling them to whom 
pays more [Fasting etal 1998]. 
 
 
 
Fig. 6a. The patient may travel to the donor country and vice-versa 
 
 
Fig. 6b. The travel of donors, recipients and surgeons for Transplantation 
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9.2 Organ sale 
Paying people to donate their kidneys is one of the most contentious ethical issues  being 
debated at the moment. The most common arguments against this practice include: 
• Donor safety 
• Unfair appeal of financial incentives to the economically disadvantaged 
• Turning the body into a money-making tool “commodity’ 
• Wealthy people would be able to access more readily 
The idea of nonfinancial incentives may be rising in popularity as a way to entice people to 
donate their organs. Financial incentives aimed at encouraging living donation have 
received much attention from bioethicists lately. Most experts argue that buying and selling 
human organs is an immoral and disrespectful practice [Daar 1998]. The moral objection 
raised most is that selling organs will appeal to the socioeconomically disadvantaged (poor, 
uneducated people) and these groups will be unfairly pressured to sell their organs by the 
promise of money. This pressure could also cause people to overlook the possible 
drawbacks in favor of cash incentives. On the other hand, wealthy people would have 
unfair access to organs due to their financial situations. It has been noticed that almost all of 
the people sold their kidneys to pay off debts and those will still had debt some time later 
but they will have a deterioration in their health status after donation and most of them 
would not recommend to others that they sell kidneys. Arguments that favor the buying 
and selling of human organs are scarce, but a few do exist. One of them is that payments 
aren’t necessarily a bad idea if they work to increase the number of donated organs. The 
position contends that donating an organ is a relatively small burden compared to the 
enormous benefit reaped by recipients. Some argues that buying and selling organs is not 
morally objectionable, but that the system as it exists is inadequate to provide appropriate 
safeguards. This critique extends not only to the medical system, but also to legal and 
religious safeguarding organizations as well. It is an important ethical issue in organ 
transplantation. Whatever the perceptions of this practice in developed countries, it is 
widespread across the world. There are regional variations in its acceptance and practice. In 
France it is crime to get involved in paid organ donation. Most of the international 
organizations and forums have called fora moratorium against the sale of organs [Budiani-
Saberi etal 2008] but the debate is not yet over. Recently the existing arguments against paid 
organ donation have been re-examined and found to be unconvincing. It is argued that the 
real reason why organ sale is generally thought to be wrong is that (a) bodily integrity is 
highly valued and (b) the removal of healthy organs constitutes a violation of this integrity 
[Wilkinson etal 1996]. Both sale and (free) donation involve a violation of bodily integrity. In 
case of free donation the violation of bodily integrity is typically outweighed by the 
presence of other goods: mainly, the extreme altruism involved in free donation. There is 
usually no such outweighing feature in the case of paid donation. Given this, the idea that 
we value bodily integrity can help to account for the perceived moral difference between 
sale and free donation. International trade in human organs, particularly in the developing 
countries of the world where cadaveric organs are not easily available and where there is 
marked disparity in wealth. As a consequence, a deplorable type of medical practice has 
emerged, where human kidneys are bought from the poor for transplantation into the 
wealthy clientele with soaring profits for brokers, private hospitals and physicians 
[Danovitch 2008]. It is estimated that since 1980, over 2,000 kidneys are sold annually in 
India, Iraq, Philippines, Iran and elsewhere. to wealthy recipients from the Middle East, the 
Far East and Europe. Human organ (“Kidneys”) trade which has shifted from India to 
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Pakistan [Noorani 2008 & Naqvi etal 2007 &Delmonico 2007]. Media, in particular had gone 
to the extent of labeling it as shifting of “Kidney Bazar”, “Bombay Bazar” from India to 
Karachi, Lahore and Islamabad [Naqvi etal 2008 & Sajjad etal 2008 & Beasley etal  2000 & 
Amerling 2001]. Fig (7). 
 
 
Fig. 7. Kidney bazar 
The drawback is that physical harm comes to one person for the benefit of another. 
However, this is considered an acceptable side effect because of the rule of choosing 
between the lesser of two maladies, i.e. one person dies and one lives, or, two people live, 
both with physical deformities.  It is not surprising, therefore, that this practice of trading in 
human organs has alarmed the medical profession, the public and many governments and it 
has rightly been condemned by all major religions, and by most transplant societies.  Organ 
sale has serious negative impact on all aspects and on everyone involved in the process of 
transplantation, including the donor, the recipient, the local transplant program, the medical 
profession and the moral and ethical values of the society. Most ethicists believe that organ 
sale is an affront not only to altruism, but also to basic human dignity as opposed to a 
utilitarian approach to the important issue of transplantation for the following main reasons: 
(a) Organ sale promotes coercion and exploitation of the poor. (b) It promotes poor quality 
of care to the donor and particularly to the recipient as a result of poor standards of donor 
selection and inadequate screening for transmissible disease. (c) It benefits ruthless 
entrepreneurs, greedy doctors who care for their egos and financial gain. It is also against 
the patient’s right for autonomy. It is contrary to accepted moral and ethical beliefs of most 
societies, including the major religions of Islam, Christianity, and Judaism. It diminishes the 
current benefit of altruistic donation by living donors and the families of cadaveric donors. 
It makes human organs a commodity for profit and sale thus inviting corruption and an 
unjust and unfair system of organ access and distribution and it predisposes to criminal 
tendencies of selling, kidnapping or killing children and women for organ sale, which has 
been reported [Spital 1997 & Danovitch etal 2006]. Some proponents of organ sale claim that 
well-controlled organ purchase does have several major advantages: by making more 
organs available it can reduce the waiting time for organs, reduce the number of deaths 
among waiting list patients as well as reduce the overall cost of treatment of patients with 
end-stage kidney disease. Some professionals in the transplant community believe that it 
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will be much more productive as well as protective from sale of organs by vendors, at least 
in the developing countries where cadaver organs are not available, if the practice of organ 
sale is regulated by an independent organization. They argue that the feeling of repugnance 
of organ sale for the rich and the healthy should not justify removing the only hope for the 
destitute and dying. Cameron and Hoffenberg [Cameron etal 1999 & Ghods etal 2006 & 
Friedman 2006 & Laurance 2008] have recommended that organs be paid for through 
nationally established organ sharing networks to ensure the quality of care received by 
donors and to promote the equity of distribution which will involve the ethical and 
medical problems that exist with organ sale. Radcliffe-Richards et al. [Radcliffe etal 1998] 
have emphasized that current exploitation of donors and lack of informed consent 
through organ purchase are due to poverty and lack of education, which do not justify 
banning organ sale. They suggest that a national organization be established to regulate 
the sale of organs or provide educational and appropriate consultation to patients to 
enable them to have informed consent and even a ‘guardian’ for the donor. Also this 
organization will regulate and control organ vending,   proper selection, payment of fees 
and provision of necessary care which will prevent the current exploitation, the risk of 
removing organs, both for the donor and the recipient, and provide screening and 
counseling, together with reliable payment and financial incentives [Friedman  E 2006 & 
Friedman Al 2006 & Surman etal 2008]. They believe that this will not affect cadaveric 
donation, since payment can also be made to the family of the deceased. Some have 
proposed a market for organ donation or sale. The proponents of this model propose a 
legitimate governmental or nonprofit nongovernmental organization to take charge for 
the responsibility of compensating the donor, without any direct contact between donors 
and recipients. This would eliminate profit-seeking middlemen and organ brokers. While 
in certain instances, this practice has led to elimination of the waiting list [Matas 2008], 
evidence for negative impact of kidney donation for the donors have been reported. The 
best is to avoid people and their organs of being a commodity in the market weather it is 
an open black market or an organized and controlled market. In addition to direct 
payment, various other forms of compensation such as life and health insurance, medal of 
honor, reimbursement for travel expenses, compensation for time out of work, or a tax 
credit have been proposed. The potential problem with this model is that if it is not well 
organized, it will open the door to an organ market, where the organs are sold to the 
highest bidder, benefiting the rich and disadvantaging the poor [Chapman 2008 & Godlee 
2008 & Thomas 2000]. Concern has also been raised that this will reduce altruistic kidney 
donation and discourage deceased multi-organ donation. However, some believe that it 
does not preclude increased donation, and others have shown that it has not inhibited the 
establishment of deceased donor transplantation programs. Opponents to any form of 
compensation and an organ market cite the concern that the poor will be viewed as mere 
providers of spare parts and will live with fewer organs, adding to this their list of 
disadvantages. According to this viewpoint, the market will be driven by poverty and the 
poor will be a disadvantage compared to the ealthier, feeling a disproportionately higher 
pressure to sell their organs Fig (8). On a global scale this could translate into people from 
rich nations travelling to poor countries to buy organs. There is the concern that the 
market could potentially lead to demeaning bodies to “articles of trade”. Degrading 
human relationships, and particularly damaging the altruistic bond. There is also the 
concern about the occasional coercion of a spouse by an addicted spouse into selling an 
organ to pay for the addiction. 
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Fig. 8. Major destination host countries WHO publications 
With related donor transplantation, altruism is the expected driving force; however, 
regarding unrelated donors, several valid question have been raised. Why should the 
unrelated donors not be at least partially rewarded for their donation?  Why should they be 
expected to undergo the surgery and live with one less organ for the rest of their lives? Are 
the other parties involved (physicians, surgeons, nurses, etc,) providing their services only 
altruistically? Why should the only individuals sacrificing their bodies not be appropriately 
acknowledged? Although current laws in most countries and guidelines by WHO and 
professional societies prohibit the sales of organs, it has been debated that provision of 
financial incentive seems not only fair, but may also encourage donation and subsequently 
benefit the patients on the waiting list [Novelli etal 2007 & Satel etal 2008 & Kranenburg etal 
2008 ]. The main opponents of providing financial incentives have voiced concern over 
“devaluing” the body to a mere commodity and the potential for commercialization. Some 
would argue that the body is a property and, in fact, the most valuable commodity that an 
individual possesses. They would contend that the owner of this property has a right to sell 
part of it for his/her better good. 
There is little doubt that commercialization of organ donation is fraught with drawbacks, 
dangers and potential immoral consequences. On the other hand, it is clear that efforts to 
increase the rate of organ donation through education have failed and sole moral incentives 
have not worked [Delmonico etal 2008 & Colakgin etal 1998 & Prasad etal 2006]. Organs are 
currently limited by supply, and in the hope of expanding the available organs, it seems 
prudent to provide incentives not only to encourage donation, but also in order to express 
appreciation. In the process, we should be cognizant of the fact that we might be sacrificing 
some good for the sake of other potentially more meritorious goods, weighing the ethical 
and morals risks of one against the other. The obligation of society is to establish safeguards 
to protect all parties involved, as well as the humane inter-relationship between donor and 
recipient. In this regard, the method of acknowledging the good deeds of donors is of 
paramount importance.  
It is clear that we need to look for feasible, ethical alternatives to the current model. This is 
not limited to whether or not donors should be compensated. Now that living unrelated 
transplant (LURT) has become an ever increasing reality Fig (9). Society and the transplant 
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community should devise safeguards to scrutinize the process [Matas 2007 & Chapman 2008 
& Godlee 2008 & Novelli etal 2007 & Satel etal 2008 &Kranenburg etal 2008 & Leung 2006]. 
 
 
Fig. 9. Trends in living related and living unrelated donors UNOS publications 
10. The struggle against international organ trafficking 
The antimarket campaign could change things. To be able to do so, however, it needs to 
embrace a strategy combining new discursive and practical elements. 
The campaign against transplant commercialism could be coherent and possibly successful 
only if it explained that the suffering-preventing capacity of a kidney disease-free and 
poverty-free world is considerably greater than that of any regulated market in organs 
[Danovitch etal 2008 & Turner 2008]. 
10.1  WHO guiding principles for cell, tissue and organ transplantation 
WHO has condemned the commercialization of organs in several occasions, starting from 
the decision of the General assembly No. 40.13 in year 1987 and No. 42.5 in year 1989, and 
requested the countries to consolidate efforts to implement the decision, then the decision 
No. 44.25 for the year 1991 which has adopted the first draft of the WHO guiding principles 
regarding the human cells, tissues and organs transplantation, and which has contoured the 
methodological and ethical standard framework.  
Among the most important recommendations issued by the general assembly, are those 
issued in its fifty-seventh session (decision 57.18) in may 2004, where the organization has 
required from the member countries the necessity of existence of an actual supervision on 
the organ transplantation, and promotion of both living and deceased donation, and to take 
the necessary measures to protect the poorest and exposed to the organs transplantation 
tourism. In year 2008, the guiding principles of the WHO have been updated regarding the 
human cells, tissues and organs transplantation [WHO 2008]. They were adopted by the 
executive council in its session held in November 2008 these guidelines are. 
• Consent for deceased donation 
• No conflict between physicians determining death 
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• Deceased but also live consenting donors 
• Minors and incompetent persons be protected 
• No sale or purchase 
• Promotion of donation no advertising nor brokering  
• Physician responsibility on origin of transplant 
• Justifiable professional fees 
• Allocation rules 
• Quality safety efficacy of procedures and transplants 
• Transparency and anonymity 
10.2 International consultation for the organization of organ transplantation  
A group of meetings were held by the WHO joined number of scientists and international 
and national organizations in order study the challenges facing human cells, tissues and 
organ transplantation. Open consultations were done in Karachi, Geneva and Madrid, 
different experts were invited The purpose of all such consultations is to determine the 
problem about such a matter and also to extract preparatory ideas in order to make them 
implemented and to encourage countries to have national or regional strategies for self 
sufficiency by promoting both living and deceased donation and to cooperate towards 
organ trafficking free world. They urge the need for an international binding treaty to 
regulate transplantation and to combat organ trafficking [Carmi 1996].  Fig (10) 
 
 
Fig. 10. 
10.3 Amsterdam forum on the care of the kidney donor: Data and medical Guidelines 
Kidney and transplant surgeons met in Amsterdam. The Netherland, from April 1-4, 2004 
for the international forum on the care of the live kidney donor. Forum participants 
included over 100 experts and leaders in Transplantation representing more than 40 
countries from around the world. The Forum analyzed the sentinel events associated with 
live kidney donation; the data emphasized the extremely low Operative mortality rates and 
the long-term safety of this procedure. Forum participants affirmed the necessity for live 
donors to receive complete medical and psychosocial evaluation prior to donation. A great 
detail of discussion focused on prevention of transmissible infectious diseases through live 
kidney transplantation [Delmonico etal 2007].  
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10.4 Lisbon conference for the care of kidney transplantation recipients in February 
2006 
An international conference about the care of the kidney transplantation recipients, held in 
Lisbon, Portugal, February 2nd-4th 2006, with the cooperation between the WHO and 
different international and national societies of organs transplantation. The conference has 
joined more than 100 experts and leaders in organ transplantation. It represents more than 
40 countries from all over the world. The conference aimed to determine the main issues 
and to set recommendations to improve the outcome of kidney transplantation all over the 
world [The Consensus Statement of the Amsterdam Forum 2004]. 
10.5 Asian campaign against organs commercialization  
A meeting was held in Taipei – January 2008, About the immoral and unfair practices 
related to the organs transplantation in Asia by local citizens and by others from other areas. 
The recommendation of the Asian campaign stressed the importance of collective measures 
against organ trafficking [Bagheri 2005]. 
10.6 Istanbul declaration 
An international summit was held in Istanbul on May 2nd 2008, joining more than 150 
representatives for medical professional, governmental and non governmental 
organizations, and transplant societies  from 78 countries and 20 international organizations, 
The meeting was organized by The Transplantation Society (TTS) and the International 
Society of Nephrology (ISN). The recommendations of Istanbul Declaration have added 
very important dimensions to the international standards of organ transplantation and 
emphasized the encouragement of living and deceased donation and stressed on the living 
donors care and to view their act as a championship as they are sharing in the Gift of life 
and the necessity to evaluate the donors medically and psychologically before and after 
donation [Steering Committee of the Istanbul Summit 2008]. The declaration was centered 
on Organ commercialism, which targets vulnerable populations (such as illiterate and 
impoverished persons, undocumented immigrants, prisoners, and political or economic 
refugees) in resource-poor countries, has been condemned by international bodies such as 
the World Health Organization for decades. Yet in recent years, as a consequence of the 
increasing ease of Internet communication and the willingness of patients in rich countries 
to travel and purchase organs, organ trafficking and transplant tourism have grown into 
global problems.  
The Istanbul Declaration proclaims that the poor who sell their organs are being exploited, 
whether by richer people within their own countries or by transplant tourists from abroad. 
Moreover, transplant tourists risk physical harm by unregulated and illegal transplantation. 
Participants in the Istanbul Summit concluded that transplant commercialism, which targets 
the vulnerable, transplant tourism, and organ trafficking should be prohibited. And they 
also urged their fellow transplant professionals, individually and through their 
organizations, to put an end to these unethical activities and foster safe, accountable 
practices that meet the needs of transplant recipients while protecting donors. 
Countries from which transplant tourists originate, as well as those to which they travel to 
obtain transplants, are just beginning to address their respective responsibilities to protect 
their people from exploitation and to develop national self-sufficiency in organ donation. 
The Declaration should reinforce the resolve of governments and international 
organizations to develop laws and guidelines to bring an end to wrongful practices. “The 
www.intechopen.com
 
Ethical Controversies in Organ Transplantation 
 
71 
legacy of transplantation is threatened by organ trafficking and transplant tourism. 
The Declaration of Istanbul aims to combat these activities and to preserve the nobility of 
organ donation. The success of transplantation as a life-saving treatment does not require—
nor justify—victimizing the world's poor as the source of organs for the rich” [Epstein 2008]  
10.7 Madrid conference March 23th-25
th
, 2010 
A conference was held in Madrid. It has concentrated about the self-sufficiency of organs for 
each country or region. The conference has recommended the necessity to set national plans 
and strategies to promote the donation of organs from deceased and living persons, arriving 
to the self-sufficiency and to fight, struggle and limit organ trafficking and transplant 
tourism.  
10.8 Global leadership symposium on organs donation  
During the period May 10th-13th, 2010, the global leadership symposium on organs donation 
was held in California. It was attended by a lot of workers in the promotion of organs 
donation and a number of the international experts in the organs donation and 
transplantation and ethicists from several countries to more support the organs donation 
and fight organ trafficking. 
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